Pembrolizumab antitumor activity in relapsed/refractory classical Hodgkin lymphoma in Keynote-087: Revised Response Criteria for Malignant Lymphoma 2007 criteria versus Lugano 2014 classification Meeting Abstract


Authors: Moskowitz, C. H.; Chen, R. W.; Armand, P.; Zinzani, P. L.; Vassilakopoulos, T. P.; Goldmacher, G. V.; Lin, J.; Nahar, A.; Balakumaran, A.; Salles, G.
Abstract Title: Pembrolizumab antitumor activity in relapsed/refractory classical Hodgkin lymphoma in Keynote-087: Revised Response Criteria for Malignant Lymphoma 2007 criteria versus Lugano 2014 classification
Meeting Title: 59th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 130
Issue: Suppl. 1
Meeting Dates: 2017 Dec 9-12
Meeting Location: Atlanta, GA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2017-12-07
Language: English
ACCESSION: WOS:000432419703096
PROVIDER: wos
DOI: 10.1182/blood.V130.Suppl_1.4085.4085
Notes: Meeting Abstract: 4085 -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Craig Moskowitz
    406 Moskowitz